Literature DB >> 10699033

Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests.

L L Jagodzinski1, D L Wiggins, J L McManis, S Emery, J Overbaugh, M Robb, S Bodrug, N L Michael.   

Abstract

Optimal management of human immunodeficiency virus type 1 (HIV-1) disease requires accurate quantitation of viral RNA concentrations in plasma. Evidence for increasing geographic intermixing of HIV-1 subtypes makes equivalent quantitation of all subtypes essential. The performances of six quantitative viral RNA tests are described, for the first time, with calibrated viral isolates of diverse subtypes.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10699033      PMCID： PMC86389     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  Impact of HIV type 1 subtype variation on viral RNA quantitation.

Authors:  B Parekh; S Phillips; T C Granade; J Baggs; D J Hu; R Respess
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-20       Impact factor: 2.205

Review 2.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary.

Authors:  W Rida; P Fast; R Hoff; T Fleming
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-11-01

4.  Subtype-specific problems with quantification of plasma HIV-1 RNA.

Authors:  A Alaeus; K Lidman; A Sönnerborg; J Albert
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

5.  HIV-1 genetic diversity.

Authors:  F E McCutchan; M O Salminen; J K Carr; D S Burke
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

6.  Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain.

Authors:  Z Debyser; E Van Wijngaerden; K Van Laethem; K Beuselinck; M Reynders; E De Clercq; J Desmyter; A M Vandamme
Journal:  AIDS Res Hum Retroviruses       Date:  1998-03-20       Impact factor: 2.205

7.  Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.

Authors:  D Brambilla; S Leung; J Lew; J Todd; S Herman; M Cronin; D E Shapiro; J Bremer; C Hanson; G V Hillyer; G D McSherry; R S Sperling; R W Coombs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

8.  Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  F S Nolte; J Boysza; C Thurmond; W S Clark; J L Lennox
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

9.  Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.

Authors:  K Triques; J Coste; J L Perret; C Segarra; E Mpoudi; J Reynes; E Delaporte; A Butcher; K Dreyer; S Herman; J Spadoro; M Peeters
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728
View more
  27 in total

1.  Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Authors:  Alessandra Amendola; Licia Bordi; Claudio Angeletti; Enrico Girardi; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Assessment of agreement between the AMPLICOR HIV-1 MONITOR test versions 1.0 and 1.5.

Authors:  Charles E Hill; Alicia M Green; Jessica Ingersoll; Kirk A Easley; Frederick S Nolte; Angela M Caliendo
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

3.  Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.

Authors:  Sihong Xu; Aijing Song; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

4.  Immiscible phase nucleic acid purification eliminates PCR inhibitors with a single pass of paramagnetic particles through a hydrophobic liquid.

Authors:  Kunal Sur; Sally M McFall; Emilie T Yeh; Sujit R Jangam; Mark A Hayden; Stephen D Stroupe; David M Kelso
Journal:  J Mol Diagn       Date:  2010-06-25       Impact factor: 5.568

5.  Comparison of the sensitivities and viral load values of the AMPLICOR HIV-1 MONITOR version 1.0 and 1.5 tests.

Authors:  Angela M Caliendo; Jessica Ingersoll; Alicia M Green; Frederick S Nolte; Kirk A Easley
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.

Authors:  Workenesh Ayele; Rob Schuurman; Tsehaynesh Messele; Wendelien Dorigo-Zetsma; Yohannes Mengistu; Jaap Goudsmit; William A Paxton; Michel P de Baar; Georgios Pollakis
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

7.  Rev-dependent indicator T cell line.

Authors:  Yuntao Wu; Margaret H Beddall; Jon W Marsh
Journal:  Curr HIV Res       Date:  2007-07       Impact factor: 1.581

8.  Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.

Authors:  Jan Felix Drexler; Luciano Kleber de Souza Luna; Celia Pedroso; Diana Brasil Pedral-Sampaio; Artur T L Queiroz; Carlos Brites; Eduardo M Netto; Christian Drosten
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

9.  Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection.

Authors:  Susanne May; Anthony Gamst; Richard Haubrich; Constance Benson; Davey M Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

10.  A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Robert F Rando; Mohamed Labib; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.